Other languages RTW Biotech Opportunities Ltd

Equities

Delayed London S.E. Other stock markets 09:23:28 2024-05-03 am EDT			5-day change	1st Jan Change
1.32 ^USD	0.00%		-0.38%	-5.88%

Apr. 05	RTW Biotech invests in cell and gene therapy company Obsidian	AN
Apr. 02	EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises	AN

RTW Biotech invests in cell and gene therapy company Obsidian	Apr. 05
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises	Apr. 02
RTW Biotech Opportunities Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Franchise Brands sets targets, Cindrigo agrees loan	Feb. 20
RTW Biotech Opportunities NAV increases 2.5% in January	Feb. 14
RTW Biotech Opportunities Completes Arix Bioscience Acquisition	Feb. 13
Katoro Gold launches fundraising, eyes board shake-up	Feb. 12
Arix Bioscience's Asset Sale to RTW Biotech Takes Effect	Feb. 12
Arix Bioscience shares suspended ahead of RTW takeover	Feb. 12
Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition	Feb. 12
Apax opts against lifting offer; DCI enters loan deal	Feb. 09
Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech	Jan. 29
Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech	Jan. 23
RTW Biotech completes Arix investment in takeover run-up	Jan. 22
RTW Biotech's manager invests USD127 million in Ji Xing	Jan. 11
RTW Biotech Opportunities invests USD127 million in investee Ji Xing	Jan. 08
Microsaic in funding talks; Jarvis says no payout	Nov. 14
RTW Biotech agrees "immediately accretive" Arix Bioscience takeover	Nov. 01
RTW Biotech Opportunities, Arix Bioscience Agree on Potential Merger Terms	Nov. 01
Brandshield shareholders approve AIM delisting	23-10-13

No results for this search